Dual Chamber Prefilled Syringes Market | Key players operating in the market include Nipro Cor, Gerresheimer AG, Vetter Pharma, Credence Medsystems, MAEDA INDUSTRY

According to recent market research "Dual Chamber Prefilled Syringes Market by Material (Glass and Plastic), Indication (Hemophilia, Schizophrenia, Endometriosis, Erectile Dysfunction, and Diabetes), Product (Liquid/Powder, Liquid/Liquid), and Region - Global Forecast to 2025 ", size is projected to grow from USD 131 million in 2020 to USD 182 million by 2025, at a CAGR of 6.8% between 2020 and 2025. The global dual chamber prefilled syringes market is witnessing growth because of the growing demand for drug delivery systems, with the growing pharmaceutical industry in the emerging economies. The increasing number of lyophilized drugs is another reason for the growing demand for dual chamber prefilled syringes, as this type of drug delivery system increases the life of the drug.

Browse 133 market data Tables and 36 Figures spread through 145 Pages and in-depth TOC on "Dual Chamber Prefilled Syringes Market - Global Forecast to 2025"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/dual-chamber-prefilled-syringes-market-132336702.html

The increasing number of patients diagnosed with hemophilia in North America and Europe and having better access to healthcare are expected to drive the demand for dual chamber prefilled syringes in this segment. Also, biologics is the only type of drug that is used for the treatment of hemophilia; this drug is lyophilized and is available only as injections.

The property of glass to be non-reactive to drugs makes it the preferred choice of material for manufacturing the chambers of dual chamber prefilled syringes. Also, the price of glass syringes is relatively low compared to plastics. These factors will drive the glass in the dual chamber prefilled syringes market.

For more Details Speak to Our Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=132336702

The global dual chamber prefilled syringes market size is projected to grow from USD 125 million in 2020 to USD 182 million by 2025, at a CAGR of 6.8% during the forecast year. The growing demand for drug delivery systems, with the growing pharmaceutical industry in the emerging economies and the increasing number of lyophilized drugs, are the key factors for the growing demand for dual chamber prefilled syringes.

The dual chamber prefilled syringes installed base market is dominated by players such as Nipro Corporation (Japan), Gerresheimer AG (Germany), Vetter Pharma (Germany), Credence Medsystems (US), MAEDA INDUSTRY (Japan), and Arte Corporation (Japan). Some of these players have adopted, new product development growth strategy to increase their market shares and enhance their product portfolios.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132336702

Gerresheimer AG is a specialty packaging product manufacturer, with a manufacturing facility across 37 locations. The company operates globally through its subsidiaries across 46 locations in Europe, the Americas, and Asia. The company produces 15 billion units of injection vials, ampoules, cartridges, containers for liquid & reliable medicines, insulin pens, pen, and micro-pump systems, inhalers, syringes, and cosmetic containers each year across its 37 manufacturing facilities.

Nipro Corporation has three business segments, namely, medical-related, pharmaceutical related, and pharma packaging. The company is involved in the manufacturing and marketing of renal products, injection products, infusion products, injectables, orally administered drugs, external preparations, glass converting, glass tubing, and devices. It manufactures dual chamber prefilled syringes under its pharmaceutical-related business segment. The company operates globally through 14 subsidiary companies and 14 manufacturing plants in eight countries, mainly focusing on the markets in Japan, the US, and the countries in Europe. The company manufactures dual-chamber prefilled syringes in its Japanese plants.

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: newsletter@marketsandmarkets.com
Press Release: https://www.marketsandmarkets.com/PressReleases/dual-chamber-prefilled-syringes.asp
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/dual-chamber-prefilled-syringes-market.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.